| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.11 | 5e-05 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.2 | 0.0005 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.84 | 0.0006 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | -0.13 | 0.001 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.19 | 0.002 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | -0.099 | 0.003 |